A few interesting items buried in the recent Investor...

A few interesting items buried in the recent Investor Presentation.

1.AnteoBind is under evaluation for use in QC testing for COVID vaccines. Could be a fairly lucrative sideline, given the number of vaccines being delivered around the globe.

2. They will be reviewing unmet clinical needs for rapid POC testing (using the Europium reader platform) in other potential indications over the next two years. They are certainly not resting of their laurels with just the current crop of projects.

3. They are aiming to increase the silicon content in anodes by up to 40% through use of AnteoX technology with a target of 75% higher energy capacity vs conventional graphite cells (currently at 25% higher capacity). They continue to strive to push the boundaries of their unique technology and who knows - the sky may well be the limit!

4.They have stated that SPP funds will be applied to battery development acceleration plus working capital. So this may give a rev up to the battery projects.

The good news just keeps coming.